Pharmafile Logo
Pharmafocus logo
Advanced Search

Changes and Challenges Ahead for Controlled Substance Manufacturers

June 7, 2012
Manufacturing and Production

Recently, several major suppliers of clinical supply services, including Catalent Pharma Solutions, haveundertaken major expansions for controlled drugs on a …

Feature
Thought Leadership

Reducing Timelines Through Strategic Outsourcing

June 7, 2012
Research and Development

Frank Lis, Vice President & General Manager, Clinical Supply Services, explores the general effects brought on by the consolidation of …

Feature
Thought Leadership
RoActemra image

RoActemra superior to Humira as single-agent therapy

June 7, 2012
Research and Development, Sales and Marketing Humira, Orencia, RA, RoActemra, Roche. ADACTA

Roche’s RoActemra (tocilizumab) is more effective in treating rheumatoid arthritis as a single agent than market leader Humira, a new …

News

Lipitor fallout prompts Pfizer to cut Irish workforce

June 7, 2012
Manufacturing and Production Amgen, Ireland, Lipitor, Pfizer, cuts, patent loss

Falling demand for blockbuster cholesterol drug Lipitor has prompted Pfizer to cut staff levels at two manufacturing facilities in Ireland. …

News

Former Teva president joins Sun Pharma

June 7, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Sun Pharma, Teva, generics, manufacturing

Sun Pharma has appointed Israel Makov as its new chairman of the board. Makov is the former president and chief …

Appointment
ABPI image

ABPI ‘fears for future of UK research’ ahead of pricing talks

June 7, 2012
Sales and Marketing ABPI, Drug pricing, PPRS, Stephen Whitehead, VBP

The UK pharmaceutical industry says too great a focus on ‘breakthrough’ drugs could undermine the future of medical research in …

News

Havas buys digital experts Creative Lynx

June 6, 2012
Medical Communications Creative Lynx, Havas, Havas Health

Havas has acquired a majority stake in Creative Lynx, one of the leading digital health communications agency in Europe. Creative …

News
ann_judge_2

Shire makes two senior appointments

June 6, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Colpman, Judge, Shire

Shire has announced the promotion of David Colpman and Ann Judge (pictured) as two senior leaders within the firm.  Colpman, …

Appointment

Global marketing access strategy: local activation

June 6, 2012
Business Services, Medical Communications, Sales and Marketing Global marketing, MSI, market access

Pharma has historically been an industry that likes to put things in boxes, neatly organising different aspects of commercialisation into …

Feature
screen_shot_2012-06-06_at_10

William Kaelin Jr elected to Lilly board

June 6, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Kaelin, lilly

Eli Lilly has elected William Kaelin Jr to its board of directors. Dr Kaelin, 54, is a Professor in the Department of …

Appointment

Merck Serono staff may strike over Geneva HQ closure

June 6, 2012
Manufacturing and Production, Research and Development ASCO, Basel, Geneva, Merck Serono, Novartis, R&D

Workers at Merck Serono’s Swiss headquarters in Geneva have threatened industrial action over the company’s plans to shut down the …

News
ASCO

Herceptin successor impresses at ASCO

June 6, 2012
Research and Development, Sales and Marketing ASCO, Cancer, EMILIA, FDA, Roche, T-DM1

Roche’s new ‘smart bomb’ breast cancer drug T-DM1 has impressed at this year’s ASCO conference in Chicago. The trial showed it …

News

AMRI wins new contract for rehabilitated facility

June 6, 2012
Manufacturing and Production AMRI, Carduium Therapeutics, FDA, Taylor

Albany Molecular Research Inc (AMRI) has won a contract to fill a newly-approved product into sterile syringes at its facility …

News

Catalent exits commercial packaging business

June 1, 2012
Manufacturing and Production Catalent, Frazier Healthcare

Catalent Pharma Solutions has decided to sell its US-based commercial packaging business to private equity group Frazier Healthcare.  Catalent said …

News
kct_2011_bournemouth_and_poole

Boehringer seeks NHS partners for COPD campaign

June 1, 2012
Medical Communications, Sales and Marketing Boehringer, COPD, disease awareness campaign

Boehringer is seeking NHS partners for its COPD campaign: ‘Know it. Check it. Treat it.’  The campaign aims to raise …

News
Bristol-Myers Squibb

BMS establishes cancer vaccine network

June 1, 2012
Research and Development, Sales and Marketing

Bristol-Myers Squibb has formed a network of ten institutions to advance work on using the body’s own immune system to …

News

ROCK medical communications appoints two new account managers

June 1, 2012
Medical Communications, Research and Development, Sales and Marketing ROCK, medical communications, pharma appointment

ROCK medical communications has appointed two new team members: Suzanne Smith and Nicola Wood. Suzanne joins from Chameleon Communications, where …

Appointment

Boehringer appoints new executive director of Consumer Healthcare Marketing

May 31, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim has announced the appointment of Ross Ullman as the executive director marketing of the Consumer Healthcare division.  In …

Appointment

Vertex admits blunder over drug data

May 31, 2012
Sales and Marketing Kalydeco, Kalydeco., Vertex, cystic fibrosis

Vertex has been embarrassed after it released claims for its pipeline drug VX-809 which turned out to be incorrect. The …

News
human genome sciences

HGS shareholder challenges ‘poison pill’

May 31, 2012
Sales and Marketing Benlysta, GSK, HGS, hostile bid

The saga of GlaxoSmithKline’s attempt to take over Human Genome Sciences (HGS) has taken another turn with legal action by …

News
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026